These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 19909356

  • 21. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB, Ballister ER, Bjorkman PJ.
    Nature; 2003 Jun 05; 423(6940):614-20. PubMed ID: 12768205
    [Abstract] [Full Text] [Related]

  • 22. Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor.
    Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, Launay P, Lehuen A, Blank U, Monteiro RC.
    Eur J Immunol; 2007 Apr 05; 37(4):1116-28. PubMed ID: 17393381
    [Abstract] [Full Text] [Related]

  • 23. Regulation of allergic inflammatory responses by inhibitory receptors.
    Shik D, Munitz A.
    Clin Exp Allergy; 2010 May 05; 40(5):700-9. PubMed ID: 20447082
    [Abstract] [Full Text] [Related]

  • 24. Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis.
    Watanabe T, Kanamaru Y, Liu C, Suzuki Y, Tada N, Okumura K, Horikoshi S, Tomino Y.
    Clin Exp Immunol; 2011 Nov 05; 166(2):235-50. PubMed ID: 21985370
    [Abstract] [Full Text] [Related]

  • 25. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA, van Egmond M.
    Immunol Lett; 2004 Mar 29; 92(1-2):23-31. PubMed ID: 15081523
    [Abstract] [Full Text] [Related]

  • 26. Molecular architecture of signal complexes regulating immune cell function.
    Torgersen KM, Aandahl EM, Taskén K.
    Handb Exp Pharmacol; 2008 Mar 29; (186):327-63. PubMed ID: 18491059
    [Abstract] [Full Text] [Related]

  • 27. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment.
    Kumanogoh A, Shikina T, Watanabe C, Takegahara N, Suzuki K, Yamamoto M, Takamatsu H, Prasad DV, Mizui M, Toyofuku T, Tamura M, Watanabe D, Parnes JR, Kikutani H.
    Int Immunol; 2005 Oct 29; 17(10):1277-82. PubMed ID: 16113236
    [Abstract] [Full Text] [Related]

  • 28. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW, Burshtyn DN.
    Sci STKE; 2001 Mar 27; 2001(75):re1. PubMed ID: 11752646
    [Abstract] [Full Text] [Related]

  • 29. Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases.
    Johnson SA, Pleiman CM, Pao L, Schneringer J, Hippen K, Cambier JC.
    J Immunol; 1995 Nov 15; 155(10):4596-603. PubMed ID: 7594458
    [Abstract] [Full Text] [Related]

  • 30. Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation.
    Kanamaru Y, Pfirsch S, Aloulou M, Vrtovsnik F, Essig M, Loirat C, Deschênes G, Guérin-Marchand C, Blank U, Monteiro RC.
    J Immunol; 2008 Feb 15; 180(4):2669-78. PubMed ID: 18250479
    [Abstract] [Full Text] [Related]

  • 31. Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins.
    Simeoni L, Lindquist JA, Smida M, Witte V, Arndt B, Schraven B.
    Immunol Rev; 2008 Aug 15; 224():215-28. PubMed ID: 18759929
    [Abstract] [Full Text] [Related]

  • 32. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
    van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, van Hattum J, Kuiper J, van de Winkel JG.
    Nat Med; 2000 Jun 15; 6(6):680-5. PubMed ID: 10835685
    [Abstract] [Full Text] [Related]

  • 33. Altering immune tolerance therapeutically: the power of negative thinking.
    Prud'homme GJ.
    J Leukoc Biol; 2004 Apr 15; 75(4):586-99. PubMed ID: 14657212
    [Abstract] [Full Text] [Related]

  • 34. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.
    Ben Mkaddem S, Benhamou M, Monteiro RC.
    Front Immunol; 2019 Apr 15; 10():811. PubMed ID: 31057544
    [Abstract] [Full Text] [Related]

  • 35. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.
    Bakema JE, van Egmond M.
    Mucosal Immunol; 2011 Nov 15; 4(6):612-24. PubMed ID: 21937986
    [Abstract] [Full Text] [Related]

  • 36. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A, van Egmond M.
    Front Immunol; 2019 Nov 15; 10():553. PubMed ID: 30984170
    [Abstract] [Full Text] [Related]

  • 37. The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.
    Waterman PM, Cambier JC.
    FEBS Lett; 2010 Dec 15; 584(24):4878-82. PubMed ID: 20875413
    [Abstract] [Full Text] [Related]

  • 38. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH, van der Steen LPE, Korthouwer RM, Hage JJ, Langedijk JPM, Benschop JJ, Bakema JE, Slootstra JW, van Egmond M.
    Eur J Immunol; 2017 Oct 15; 47(10):1835-1845. PubMed ID: 28736835
    [Abstract] [Full Text] [Related]

  • 39. Role of IgA and IgA fc receptors in inflammation.
    Monteiro RC.
    J Clin Immunol; 2010 Jan 15; 30(1):1-9. PubMed ID: 19834792
    [Abstract] [Full Text] [Related]

  • 40. The role of IgA and IgA Fc receptors as anti-inflammatory agents.
    Monteiro RC.
    J Clin Immunol; 2010 May 15; 30 Suppl 1():S61-4. PubMed ID: 20405182
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.